Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP526813.RAUTqx68oXKScHpB1G0fLqognvLjrr8QWMTPVAnzOWSMk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP526813.RAUTqx68oXKScHpB1G0fLqognvLjrr8QWMTPVAnzOWSMk130_assertion type Assertion NP526813.RAUTqx68oXKScHpB1G0fLqognvLjrr8QWMTPVAnzOWSMk130_head.
- NP526813.RAUTqx68oXKScHpB1G0fLqognvLjrr8QWMTPVAnzOWSMk130_assertion description "[These findings support the therapeutic potential of intraperitoneal administration of OBP-301 to sensitize ovarian cancer cells to CDDP.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP526813.RAUTqx68oXKScHpB1G0fLqognvLjrr8QWMTPVAnzOWSMk130_provenance.
- NP526813.RAUTqx68oXKScHpB1G0fLqognvLjrr8QWMTPVAnzOWSMk130_assertion evidence source_evidence_literature NP526813.RAUTqx68oXKScHpB1G0fLqognvLjrr8QWMTPVAnzOWSMk130_provenance.
- NP526813.RAUTqx68oXKScHpB1G0fLqognvLjrr8QWMTPVAnzOWSMk130_assertion SIO_000772 19662088 NP526813.RAUTqx68oXKScHpB1G0fLqognvLjrr8QWMTPVAnzOWSMk130_provenance.
- NP526813.RAUTqx68oXKScHpB1G0fLqognvLjrr8QWMTPVAnzOWSMk130_assertion wasDerivedFrom befree-20150227 NP526813.RAUTqx68oXKScHpB1G0fLqognvLjrr8QWMTPVAnzOWSMk130_provenance.
- NP526813.RAUTqx68oXKScHpB1G0fLqognvLjrr8QWMTPVAnzOWSMk130_assertion wasGeneratedBy ECO_0000203 NP526813.RAUTqx68oXKScHpB1G0fLqognvLjrr8QWMTPVAnzOWSMk130_provenance.